<DOC>
	<DOCNO>NCT01123070</DOCNO>
	<brief_summary>The purpose study determine safety pharmacology TL011 patient severe rheumatoid arthritis .</brief_summary>
	<brief_title>TL011 Severe , Active Rheumatoid Arthritis Patients</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Adult subject Rheumatoid arthritis define 1987 ACR Classification Severe active seropositive disease Inadequate response intolerance DMARDs Treatment MTX Rheumatic autoimmune disease RA Active infection Known immunodeficiency syndrome Positive Hepatitis B surface antigen antibody Hepatitis C History cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>